The Nuts & Bolts of Due Diligence in Biopharma Partnering
What's Hot and What's Not in Oncology Licensing in 2020?
How to Win at the Partnering Game
In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy.
Preparing For Your Exit
Precision Medicine in Central Nervous System Drug Development
Microbiome: Hope or Hype?
National Institute of Health Small Business Programs
What’s Hot & What’s Not in Immuno-Oncology Licensing
The Nuts & Bolts of Selecting a Contract Research Organization
This whitepaper discusses how to determine internal champions/selection committees, strategic sourcing/Procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value.
Gene & Cell Therapies
Non-Immuno-Oncology and Immuno-Oncology Partnering and Development: What’s the Role of Non-IO in an IO World?